clodronic acid has been researched along with Osteonecrosis in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (38.89) | 29.6817 |
| 2010's | 10 (55.56) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Halling, F; Lux, C; Otto, M; Schlittenbauer, T; Ziebart, T | 1 |
| Cavo, M; Dimopoulos, MA; Drake, MT; Durie, BG; García-Sanz, R; Jurczyszyn, A; Leleu, X; Lentzsch, S; Merlini, G; Morgan, G; Munshi, N; Raje, N; Rajkumar, SV; Reiman, T; Roodman, GD; Sezer, O; Shimizu, K; Spencer, A; Terpos, E; Turesson, I | 1 |
| Alons, K; de Jong, E; Kuijpers, SC; van Merkesteyn, JP | 1 |
| Endo, Y; Funayama, H; Kawamura, H; Kuroishi, T; Oizumi, T; Sugawara, S; Yamaguchi, K | 1 |
| Capodiferro, S; Favia, G; Iezzi, G; Piattelli, A; Sportelli, P | 1 |
| Crépin, S; Laroche, ML; Merle, L; Sarry, B | 1 |
| Bainton, R; Hindawi, M; Srinivasan, D | 1 |
| Bauss, F; Drosse, I; Ehrenfeld, M; Opelz, C; Otto, S; Pautke, C; Schieker, M; Schwager, J; Westphal, I | 1 |
| Kyrgidis, A; Tzellos, TG | 1 |
| Kami, M; Matayoshi, T; Takeuchi, K; Tanimoto, T; Yagasaki, F | 1 |
| Morgan, GJ | 1 |
| Carrassi, A; Lodi, G; Sardella, A; Tarozzi, M | 1 |
| Azambuja, AA; Berti-Couto, SA; Cherubini, K; da Silva, VD; Figueiredo, MA; Salum, FG; Vasconcelos, AC | 1 |
| Ben-Dor, D; Lugassy, G; Nahlieli, O; Nemets, A; Shaham, R | 1 |
| Gralow, J | 1 |
| Bagis, B; Durmus, A; Saracoglu Tekin, U; Senel, FC | 1 |
| Erskine, JG; McQuaker, IG; Montazeri, AH | 1 |
| Márton, I; Redl, P; Udvardy, E | 1 |
3 review(s) available for clodronic acid and Osteonecrosis
| Article | Year |
|---|---|
Osteonecrosis of the jaw induced by clodronate, an alkylbiphosphonate: case report and literature review.
Topics: Administration, Oral; Bone Density Conservation Agents; Clodronic Acid; Diphosphonates; Drug Administration Schedule; Female; Humans; Mandible; Middle Aged; Oral Surgical Procedures; Osteonecrosis; Tooth Extraction | 2010 |
Evolving role of bisphosphonates in women undergoing treatment for localized and advanced breast cancer.
Topics: Antineoplastic Agents; Aromatase Inhibitors; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Chemotherapy, Adjuvant; Clodronic Acid; Diphosphonates; Female; Humans; Imidazoles; Osteonecrosis; Pamidronate; Quality of Life; Randomized Controlled Trials as Topic; United States; Women's Health; Zoledronic Acid | 2005 |
[Osteonecrosis of the jaw developing during bisphosphonate treatment].
Topics: Alendronate; Anti-Infective Agents; Bone Density Conservation Agents; Bone Neoplasms; Bone Remodeling; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Ibandronic Acid; Imidazoles; Mandible; Mandibular Diseases; Oral Hygiene; Oral Surgical Procedures; Osteonecrosis; Patient Care Team; Referral and Consultation; Zoledronic Acid | 2008 |
2 trial(s) available for clodronic acid and Osteonecrosis
| Article | Year |
|---|---|
Safety and efficacy of zoledronic acid in multiple myeloma.
Topics: Clodronic Acid; Diphosphonates; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Female; Humans; Imidazoles; Incidence; Male; Multiple Myeloma; Osteonecrosis; Prognosis; Risk Assessment; Safety Management; Severity of Illness Index; Survival Analysis; Thromboembolism; Zoledronic Acid | 2011 |
Safety and efficacy of zoledronic acid in multiple myeloma.
Topics: Clodronic Acid; Diphosphonates; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Imidazoles; Male; Multiple Myeloma; Osteonecrosis; Prognosis; Risk Assessment; Safety Management; Survival Analysis; Thromboembolism; Treatment Outcome; Zoledronic Acid | 2011 |
13 other study(ies) available for clodronic acid and Osteonecrosis
| Article | Year |
|---|---|
Geranyl-geraniol addition affects potency of bisphosphonates-a comparison in vitro promising a therapeutic approach for bisphosphonate-associated osteonecrosis of the jaw and oral wound healing.
Topics: Acyclic Monoterpenes; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Clodronic Acid; Diphosphonates; Endothelial Cells; Humans; Ibandronic Acid; Jaw Diseases; Mouth Diseases; Osteonecrosis; Wound Healing; Zoledronic Acid | 2022 |
International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease.
Topics: Administration, Intravenous; Bone Density Conservation Agents; Bone Diseases; Clodronic Acid; Combined Modality Therapy; Diphosphonates; Drug Therapy, Combination; Fractures, Bone; Humans; Imidazoles; International Cooperation; Magnetic Resonance Imaging; Medical Oncology; Multiple Myeloma; Osteonecrosis; Outcome Assessment, Health Care; Pamidronate; Positron-Emission Tomography; Practice Guidelines as Topic; Radiotherapy; Tomography, X-Ray Computed; Zoledronic Acid | 2013 |
Treating low- and medium-potency bisphosphonate-related osteonecrosis of the jaws with a protocol for the treatment of chronic suppurative osteomyelitis: report of 7 cases.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Bone Density Conservation Agents; Chronic Disease; Clinical Protocols; Clodronic Acid; Debridement; Dental Implants; Diphosphonates; Female; Humans; Injections, Intravenous; Jaw Diseases; Middle Aged; Osteomyelitis; Osteonecrosis; Pamidronate; Retrospective Studies; Tooth Extraction | 2009 |
Necrotic actions of nitrogen-containing bisphosphonates and their inhibition by clodronate, a non-nitrogen-containing bisphosphonate in mice: potential for utilization of clodronate as a combination drug with a nitrogen-containing bisphosphonate.
Topics: Animals; Bone Density Conservation Agents; Clodronic Acid; Diphosphonates; Drug Combinations; Drug Eruptions; Female; Injections, Intraperitoneal; Mice; Mice, Inbred BALB C; Nitrogen; Osteonecrosis; Skin; Structure-Activity Relationship | 2009 |
Osteonecrosis of the posterior mandible after implant insertion: a clinical and histological case report.
Topics: Aged; Bone Density Conservation Agents; Clodronic Acid; Dental Implants; Female; Humans; Mandibular Diseases; Osseointegration; Osteonecrosis; Treatment Failure | 2011 |
Non-surgical management of stage 3 biphosphonate-related oroantral fistula.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Local; Bone Density Conservation Agents; Clindamycin; Clodronic Acid; Diphosphonates; Female; Follow-Up Studies; Humans; Hydrogen Peroxide; Ibandronic Acid; Maxillary Diseases; Middle Aged; Oroantral Fistula; Osteonecrosis; Povidone-Iodine; Tooth Extraction | 2011 |
Osteonecrosis of the jaw: effect of bisphosphonate type, local concentration, and acidic milieu on the pathomechanism.
Topics: Bone Density Conservation Agents; Cell Line; Cell Movement; Cell Proliferation; Cell Shape; Cell Survival; Clodronic Acid; Diphosphonates; Dose-Response Relationship, Drug; Fluorescent Dyes; Humans; Hydrogen-Ion Concentration; Ibandronic Acid; Imidazoles; Jaw Diseases; Mesenchymal Stem Cells; Osteonecrosis; Time Factors; Zoledronic Acid | 2010 |
Further analyses of the Myeloma IX Study.
Topics: Bone Density Conservation Agents; Clodronic Acid; Diphosphonates; Humans; Imidazoles; Multiple Myeloma; Osteonecrosis; Thrombosis; Zoledronic Acid | 2011 |
Bisphosphonate-related osteonecrosis of the jaws associated with photodynamic therapy.
Topics: Aged; Bone Density Conservation Agents; Carcinoma, Verrucous; Clodronic Acid; Female; Humans; Leukoplakia, Oral; Mandibular Diseases; Mandibular Neoplasms; Mesoporphyrins; Neoplasm Recurrence, Local; Osteonecrosis; Osteoporosis; Photochemotherapy; Photosensitizing Agents | 2011 |
Comparison of effects of clodronate and zoledronic acid on the repair of maxilla surgical wounds - histomorphometric, receptor activator of nuclear factor-kB ligand, osteoprotegerin, von Willebrand factor, and caspase-3 evaluation.
Topics: Animals; Bacterial Load; Bone Density Conservation Agents; Caspase 3; Clodronic Acid; Connective Tissue; Diphosphonates; Epithelium; Female; Imidazoles; Maxilla; Maxillary Diseases; Mouth Mucosa; Osteonecrosis; Osteoprotegerin; RANK Ligand; Rats; Rats, Wistar; Tooth Extraction; Tooth Socket; von Willebrand Factor; Wound Healing; Zoledronic Acid | 2012 |
Severe osteomyelitis of the jaw in long-term survivors of multiple myeloma: a new clinical entity.
Topics: Actinomyces; Actinomycosis; Aged; Antimetabolites; Clodronic Acid; Female; Humans; Jaw; Male; Middle Aged; Multiple Myeloma; Necrosis; Osteomyelitis; Osteonecrosis; Severity of Illness Index; Survivors | 2004 |
Severe osteomyelitis of the mandible associated with the use of non-nitrogen-containing bisphosphonate (disodium clodronate): report of a case.
Topics: Actinomycosis; Aged; Bone Density Conservation Agents; Clodronic Acid; Female; Humans; Mandibular Diseases; Multiple Myeloma; Osteomyelitis; Osteonecrosis; Tooth Extraction | 2007 |
Oral sodium clodronate induced osteonecrosis of the jaw in a patient with myeloma.
Topics: Adult; Clodronic Acid; Humans; Jaw Diseases; Male; Multiple Myeloma; Osteonecrosis | 2007 |